Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals

Chronic infection with hepatitis C virus (HCV) may complicate with hepatocellular carcinoma (HCC), especially in patients with cirrhosis. Although the achievement of a sustained virological response (SVR) had been associated with a reduction in the risk of HCC already in the Interferon era, some con...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Ambrosio, Roberta, Degasperi, Elisabetta, Lampertico, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254542/
https://www.ncbi.nlm.nih.gov/pubmed/34235108
http://dx.doi.org/10.2147/JHC.S292139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254542/
https://www.ncbi.nlm.nih.gov/pubmed/34235108
http://dx.doi.org/10.2147/JHC.S292139

Ejemplares similares